Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in schizophrenia (BETA trial)
NCT00237939Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Sep 2002
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of aripiprazole in schizophrenia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Sep 2002; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00237939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237939.